Microcapsules
AssigneeZeneca Limited
InventorsHerbert B. Scher, Marius Rodson
Life of this patent
Estimating the term…
Loading patent…
AssigneeZeneca Limited
InventorsHerbert B. Scher, Marius Rodson
Estimating the term…
A process is disclosed for the microencapsulation of a substantially water-insoluble liquid material within a porous shell to effect a slow rate of release of said material through said shell which comprises (a) providing an organic solution comprising said material and an etherified urea-formaldehyde prepolymer dissolved therein in which from about 50% to about 98% of the methylol groups of said prepolymer have been etherified with a C.sub.4 -C.sub.10 alcohol; (b) creating an emulsion of said organic solution in an continuous phase aqueous solution comprising water and a surfaceactive agent, wherein said emulsion comprises discrete droplets of said organic solution dispersed in said continuous phase aqueous solution, there being formed thereby an interface between the discrete droplets of organic solution and the surrounding continuous phase aqueous solution; and (c) causing in situ self-condensation and curing of said ureaformaldehyde prepolymers in the organic phase of said discrete droplets adjacent to said interface by simultaneously heating said emulsion to a temperature between about 20.degree. C. to about 100.degree. C., and adding to said emulsion an acidifying agent and maintaining said emulsion at a pH of between about 0 to about 4 for a sufficient period of time to allow substantial completion of in situ condensation of said resin prepolymers to convert the liquid droplets of said organic solution to capsules consisting of solid permeable polymer shells enclosing said liquid material. Also disclosed are the microcapsules formed by the above-described process.
A microcapsule comprising a liquid core material which is substantially insoluble in water, enclosed within a solid permeable shell of self-condensed etherified urea-formaldehyde polymer, said shell comprising from about 1 to about 25 weight percent of the microcapsule.
Dependencies are inferred from the claim text.